Stereotactic Radiosurgery · Technical Foundations

Imaging, Registration & Immobilization

Putting the dose where the target actually is

Radiosurgery's precision is only as good as its localization chain: the imaging that defines the target, the registration that places it in treatment coordinates, and the immobilization and image guidance that keep it there during delivery. Each link has a characteristic failure mode, and the most consequential one, image mis-registration or MRI geometric distortion, is invisible on the treatment console. This page walks the chain and where it breaks.

Orientation

Three things must align to a fraction of a millimeter: where the target is on imaging, where the planning system thinks it is in space, and where the beam actually goes. The planning CT provides the geometry and electron density for dose calculation; MRI provides the soft-tissue definition; their fusion ties the two together; immobilization fixes the patient; and image guidance verifies position at treatment. Errors at the imaging/fusion step are the most dangerous because, unlike a setup error, they are baked into the plan and reproduced at every fraction.

Part I

Imaging & Registration

1.The CT-MRI partnership, acquisition quality, and image age

A thin, contiguous planning CT is the geometrically faithful reference and supplies electron density for dose calculation, while MRI supplies the soft-tissue definition for most cranial targets. The two are rigidly co-registered. The planning MRI should use a stereotactic protocol with an isotropic or near-isotropic dataset, no interslice gap, and distortion correction appropriate to the scanner and sequence. For brain metastases, the planning post-contrast 3D T1 dataset should be ≤1 mm: thicker images can miss small lesions and materially change their contoured volume.

Image quality is not enough if the anatomy has changed. Planning imaging should be obtained as close to treatment as practical. For brain metastases, a useful operational standard is MRI acquired within 7 days of SRS; same-day stereotactic imaging remains ideal for frame-based Gamma Knife workflows. Repeat or update imaging sooner when the target is large or rapidly changing, when edema or corticosteroid dosing has shifted, after recent surgery, or when the neurologic examination changes. A diagnostic MRI several weeks old may establish the indication, but it should not automatically define the treatment volume.

Planning-imaging rule Use the newest high-quality stereotactic dataset, not merely the newest scan. For metastases, aim for planning MRI within 7 days of treatment and shorten that interval when growth, postoperative cavity change, edema, steroid response, or new symptoms make the target biologically unstable.

2.Indication-specific MRI and adjunct imaging

The core tumor sequence is best described without tying it to one vendor: a thin-slice isotropic 3D post-contrast T1-weighted acquisition, commonly an inversion-prepared gradient-echo sequence such as MPRAGE, SPGR/BRAVO, or TFE. For metastases, post-contrast 3D turbo spin echo or black-blood techniques such as SPACE, CUBE, or VISTA can complement the gradient-echo dataset by suppressing vascular signal and improving conspicuity of small lesions. Specialized targets need specialized anatomy:

Representative planning studies by indication. Use the validated local protocol and acquire the planning dataset as close to treatment as practical.
IndicationCore planning imagingProblem-solving / adjunct imaging
Brain metastases≤1 mm isotropic pre/post-contrast 3D T1 (MPRAGE, SPGR/BRAVO, or TFE); T2/FLAIR; DWIPost-contrast 3D TSE/black-blood (SPACE, CUBE, or VISTA); delayed post-contrast acquisition, commonly 5 to 15 minutes after injection with other sequences run during the interval
Vestibular / cranial-nerve schwannomaThin post-contrast 3D T1 plus heavily T2-weighted cisternography (CISS/FIESTA/SPACE)Thin CT for internal auditory canal, cochlea, or complex skull-base bone
MeningiomaVolumetric post-contrast 3D T1; T2/FLAIR for edema and brain interfaceThin CT for hyperostosis and bone; selected somatostatin-receptor PET for complex skull-base, postoperative, or equivocal disease
Pituitary / parasellarDedicated thin pre/post-contrast sellar T1 and T2 with precise optic-apparatus definitionDynamic contrast for microadenoma; fat suppression when postoperative graft or fat obscures the target
Trigeminal neuralgiaHigh-resolution heavily T2-weighted cisternography through the trigeminal nerve and root entry zoneThin post-contrast 3D T1; TOF-MRA when vascular anatomy or neurovascular conflict needs clarification
Tremor / functional thalamotomyIsotropic stereotactic 3D T1 with AC-PC definition; FGATIR for thalamic, capsular, and adjacent white-matter anatomyDRTT diffusion tractography as an adjunct; atlas/coordinate targeting remains the validated framework
AVMStereotactic catheter angiography plus MRI/MRA for nidus and surrounding brainTOF or time-resolved MRA; CTA when useful for calcification, embolic material, or angioarchitecture
Cavernous malformationT2 and susceptibility-sensitive GRE/SWI to define the lesion and hemosiderin boundaryPost-contrast 3D T1 and DVA assessment; target the malformation, not the surrounding hemosiderin-stained brain
Epilepsy / hypothalamic hamartomaIsotropic 3D T1 plus thin coronal T2/FLAIR oriented to the hippocampi or lesionDedicated epilepsy-protocol sequences and functional/metabolic studies according to the presurgical hypothesis
Spine SBRTThin T1 and T2 co-registered to planning CT for tumor, cord, and thecal sacCT myelography when MRI is degraded by hardware, contraindicated, or insufficient for cord definition

FGATIR and tractography add anatomical context for Vim targeting but should not be presented as infallible direct visualization. The thalamic target remains a synthesis of stereotactic landmarks, atlas anatomy, patient-specific imaging, and the treatment team's validated method. Likewise, a CT-only cranial workflow is a fallback for MRI contraindication, not an equivalent default; the loss of soft-tissue discrimination must be recognized explicitly.

3.MRI geometric distortion: the quiet hazard

MRI is geometrically imperfect. Gradient nonlinearity, main-field inhomogeneity, and susceptibility and chemical-shift effects can displace anatomy by clinically meaningful distances, worsening toward the periphery of the field of view and at air/bone interfaces (skull base). In one radiosurgery series the median target displacement caused by gradient nonlinearity alone was 1.2 mm with a maximum of 3.9 mm, and 8 of 28 cases met a predefined criterion for geometric miss; AAPM Task Group 284 reports residual distortion after vendor correction exceeding 1 mm beyond roughly 10 cm from magnet isocenter. Because radiosurgery uses essentially no margin, an uncorrected distortion places the contour, and the dose, off target. Mitigation includes vendor distortion-correction algorithms, which correct system gradient nonlinearity but not patient-induced susceptibility distortion, distortion-optimized sequences with high receiver bandwidth, deliberate phase-encode direction choice, centering the head at magnet isocenter rather than at the coil, QA phantoms to characterize residual distortion at commissioning and at least annually, and, critically, using the geometrically faithful CT as the spatial reference and verifying the fusion on multiple planes and landmarks rather than trusting an automated result.

Verify the fusion; respect MR distortion The commonest serious radiosurgery error is geometric, not mechanical: a mis-registration or uncorrected MRI distortion that moves the target. Confirm CT-MRI fusion against bony and vascular landmarks on multiple planes, apply distortion correction, and be especially wary at the periphery of the MR field of view and near the skull base. A perfectly delivered plan onto a mislocalized target is precisely wrong.
Part II

Immobilization

4.Frame, mask, and body systems

Immobilization trades invasiveness for repeatability:

  • Invasive stereotactic frame (e.g., Leksell coordinate frame): pinned to the skull, it provides a rigid coordinate system and the highest single-session accuracy (sub-millimeter), the historical standard for single-fraction cranial SRS.
  • Thermoplastic mask (frameless): non-invasive and necessary for most fractionated workflows. Validated image-guided systems can achieve sub-millimeter end-to-end accuracy, but masks show greater setup and intrafraction variability than rigid frames; performance belongs to the complete chain of mask, image guidance, correction, motion threshold, and beam-hold policy, not to the mask alone.
  • Body immobilization: vacuum bags and stereotactic body frames for spine/trunk, with abdominal compression, breath-hold, or gating to manage respiratory motion for thoracic/abdominal SBRT.

The key point is that frameless accuracy is not a property of the mask alone: it depends on the image-guidance and motion-monitoring system that accompanies it.

Part III

Image Guidance at Treatment

5.Seeing and correcting position before and during delivery

Modern delivery is image-guided. Cone-beam CT verifies volumetric position; stereoscopic kV imaging (e.g., ExacTrac) localizes bony anatomy and supports six-degree-of-freedom (6DOF) couch correction; optical surface monitoring (e.g., surface-guided systems) tracks the patient surface for setup and intrafraction motion, triggering a beam hold if the patient moves. Spine SBRT relies on bony (vertebral) tracking; mobile body targets use implanted fiducials and respiratory tracking (e.g., the robotic Synchrony approach). The radiation-isocenter accuracy underlying all of this is verified by the Winston-Lutz test and the broader QA program on the planning and QA page.

Immobilization and guidance approaches (representative; accuracy depends on the full guidance chain).
ApproachSettingRepresentative accuracyNotes
Invasive stereotactic frameSingle-fraction cranialSub-millimeterRigid coordinate system; historical SRS standard
Thermoplastic mask + IGRTCranial SRS/SRT, fractionatedSub-mm end-to-end is achievable on validated systems; variability exceeds frame fixationRequires volumetric verification, correction, and intrafraction monitoring
Body frame / vac-bag (+ motion mgmt)Spine/body SBRTSpine SBRT with volumetric image guidance, about 1–2 mm; mobile thoracic and abdominal targets, several millimeters unless respiratory motion is actively managed and verified on the unitCompression/gating/breath-hold for respiratory motion

Key points

  • The localization chain is CT (geometry/density) + MRI (soft tissue) + fusion + immobilization + image guidance; errors at imaging/fusion are baked into every fraction.
  • Planning imaging should be recent enough to represent the target at treatment; for brain metastases, aim for MRI within 7 days and repeat sooner when the anatomy is unstable.
  • Use indication-specific imaging: isotropic 3D post-contrast T1 (MPRAGE/SPGR/BRAVO/TFE) for tumors, CISS/FIESTA for cranial nerves, FGATIR as an adjunct for tremor targeting, TOF-MRA + DSA for AVM, and dynamic sellar imaging for pituitary.
  • MRI geometric distortion (gradient nonlinearity, susceptibility, chemical shift) can move targets, worse peripherally and at skull base: correct it and use CT as the spatial reference.
  • Frame remains the rigid sub-mm single-session standard; mask-based systems can also achieve sub-mm end-to-end performance, but only as a validated image-guidance and intrafraction-monitoring chain.
  • Delivery guidance: CBCT, stereoscopic kV (ExacTrac), surface monitoring, 6DOF couch; spine uses bony tracking, mobile body uses fiducials/respiratory tracking; isocenter verified by Winston-Lutz.
  • The most dangerous error is geometric (fusion/distortion), not mechanical: verify the fusion.

References

  1. Winston KR, Lutz W. Linear accelerator as a neurosurgical tool for stereotactic radiosurgery. Neurosurgery. 1988;22(3):454–464. PubMed
  2. Klein EE, Hanley J, Bayouth J, et al. Task Group 142 report: quality assurance of medical accelerators. Med Phys. 2009;36(9):4197–4212. PubMed
  3. Seibert TM, White NS, Kim GY, et al. Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning. Pract Radiat Oncol. 2016;6(6):e319–e328. PubMed
  4. Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078–4101. PubMed
  5. Wright G, Harrold N, Hatfield P, Bownes P. Validity of the use of nose tip motion as a surrogate for intracranial motion in mask-fixated frameless Gamma Knife Icon therapy. J Radiosurg SBRT. 2017;4(4):289–301. PubMed
  6. Kaufmann TJ, Smits M, Boxerman J, et al. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol. 2020;22(6):757–772. PubMed
  7. Thrower SL, Al Feghali KA, Luo D, et al. The effect of slice thickness on contours of brain metastases for stereotactic radiosurgery. Adv Radiat Oncol. 2021;6(4):100708. PubMed
  8. Grishchuk D, Dimitriadis A, Sahgal A, et al. ISRS technical guidelines for stereotactic radiosurgery: treatment of small brain metastases (≤1 cm in diameter). Pract Radiat Oncol. 2023;13(3):183–194. PubMed
  9. Garcia MA, Anwar M, Yu Y, et al. Brain metastasis growth on preradiosurgical magnetic resonance imaging. Pract Radiat Oncol. 2018;8(6):e369–e376. PubMed
  10. Lehman VT, Lee KH, Klassen BT, et al. MRI and tractography techniques to localize the ventral intermediate nucleus and dentatorubrothalamic tract for deep brain stimulation and MR-guided focused ultrasound: a narrative review and update. Neurosurg Focus. 2020;49(1):E8. PubMed

Educational synthesis for neurosurgery and radiation-oncology trainees; immobilization accuracy figures are representative and depend on the complete guidance chain. Imaging, distortion, and QA references verified against PubMed during review.